News

Filter

Current filters:

AstraZenecaPfizer

1 to 9 of 481 results

World’s largest collection of deprioritized pharma compounds opens to researchers

World’s largest collection of deprioritized pharma compounds opens to researchers

09-12-2014

A collection of 68 deprioritized pharmaceutical compounds is being made available to academic researchers…

AstraZenecaEli LillyGlaxoSmithKlineJanssen Research & DevelopmentPfizerPharmaceuticalResearchTakeda PharmaceuticalUCBUK

FDA revokes tentative approval of Ranbaxy’s generic Nexium and Valcyte

07-11-2014

Indian generics drugmaker Ranbaxy Laboratories revealed in a Bombay Stock Exchange filing that it has…

Anti-viralsAstraZenecaGastro-intestinalsGenericsNexiumPfizerRanbaxy LaboratoriesRegulationSun PharmaceuticalUSAValcyte

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

22-08-2014

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer…

ActavisAstraZenecaBusiness FinanceIrelandMergers & AcquisitionsPfizerPharmaceuticalSwedenUKUnited StatesUSA

Seven pharma companies offer up compounds to UK researchers

Seven pharma companies offer up compounds to UK researchers

22-07-2014

UK researchers will be granted access to a ‘virtual library’ of deprioritized pharmaceutical compounds…

AstraZenecaEli LillyGlaxoSmithKlineJanssenMedical Research CouncilPfizerPharmaceuticalResearchTakeda PharmaceuticalUCBUK

AstraZeneca safe (for now?) as Pfizer walks away from pursuit of the firm

26-05-2014

US pharma giant Pfizer, which has been involved in a controversial pursuit of UK-based AstraZeneca, has…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

AstraZeneca rejects Pfizer’s improved and “final” offer of £55 a share

AstraZeneca rejects Pfizer’s improved and “final” offer of £55 a share

19-05-2014

After what must have been a hectic weekend of cross Atlantic activity, the board of Anglo-Swedish drug…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

Now waiting for next move from Pfizer in AstraZeneca bid

Now waiting for next move from Pfizer in AstraZeneca bid

16-05-2014

With the UK Parliamentary investigation now over – but no report out yet – all eyes are on US pharma…

AstraZenecaMergers & AcquisitionsPfizer

1 to 9 of 481 results

Back to top